Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T25462 | Target Info | |||
Target Name | Mixed-lineage leukemia protein (MLL) | ||||
Synonyms | p320; p180; Zinc finger protein HRX; Trithoraxlike protein; Trithorax-like protein; Myeloid/lymphoid or mixed-lineage leukemia protein 1; Myeloid/lymphoid or mixed-lineage leukemia; MLL1; MLL cleavage product C180; Lysine Nmethyltransferase 2A; Lysine N-methyltransferase 2A; Histonelysine Nmethyltransferase MLL; Histone-lysine N-methyltransferase 2A; HTRX; HRX; CXXCtype zinc finger protein 7; CXXC7; CXXC-type zinc finger protein 7; ALL1; ALL-1 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | KMT2A | ||||
Biochemical Class | Methyltransferase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Beta-transducin repeats | [+] 1 Beta-transducin repeats | + | |||
Interacting Target Name | WD repeat-containing protein 5 (WDR5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BMP2-induced 3-kb gene protein; BIG3 | ||||
Evidence Score (E-score) | 11 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Co-purification | [1] | |||
6 | Co-purification | [5] | |||
7 | Protein-peptide | [3] | |||
8 | Reconstituted Complex | [6] | |||
9 | Reconstituted Complex | [5] | |||
10 | Reconstituted Complex | [7] | |||
11 | Reconstituted Complex | [8] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Affinity Capture-Western | [10] | |||
3 | Reconstituted Complex | [9] | |||
Histones | [+] 1 Histones | + | |||
Interacting Protein Name | Histone H3.1 (H31) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | H3/A; H3FA | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Biochemical Activity | [8] | |||
2 | Biochemical Activity | [11] | |||
3 | Biochemical Activity | [10] | |||
4 | Co-crystal Structure | [12] | |||
5 | Reconstituted Complex | [13] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Protein Name | Peptidyl-prolyl cis-trans isomerase E (PPIE) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CYP.33; CYP33 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Affinity Capture-Western | [15] | |||
3 | Co-crystal Structure | [12] | |||
4 | Yeast two hybrid | [14] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [16] | |||
2 | Reconstituted Complex | [17] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [18] | |||
2 | Co-crystal Structure | [19] | |||
3 | Reconstituted Complex | [19] | |||
4 | Yeast two hybrid | [18] | |||
Other proteins | [+] 8 Other proteins | + | |||
Interacting Protein Name | Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2L) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ASH2; ASH2L1; ASH2L2; Bre2 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Biochemical Activity | [11] | |||
5 | Co-purification | [1] | |||
6 | Co-purification | [5] | |||
7 | Reconstituted Complex | [7] | |||
8 | Reconstituted Complex | [5] | |||
Interacting Protein Name | Menin (MEN1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MEAI; SCG2 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [20] | |||
3 | Affinity Capture-Western | [21] | |||
4 | Affinity Capture-Western | [22] | |||
5 | Affinity Capture-Western | [23] | |||
6 | Co-localization | [22] | |||
7 | Co-purification | [1] | |||
8 | Reconstituted Complex | [21] | |||
Interacting Protein Name | Retinoblastoma-binding protein 5 (RBBP5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RBQ3; SWD1 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [24] | |||
5 | Co-purification | [1] | |||
6 | Co-purification | [5] | |||
7 | Reconstituted Complex | [7] | |||
8 | Reconstituted Complex | [5] | |||
Interacting Protein Name | Host cell factor 1 (HCFC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CFF; HCF; HCF.1; HCF1; HFC1; MRX3; PPP1R89; VCAF | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Co-purification | [1] | |||
Interacting Target Name | Beta-catenin (CTNNB1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Wnt/beta-catenin signaling pathway; PRO2286; OK/SW-cl.35; CTNNB; Catenin beta-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [25] | |||
2 | Reconstituted Complex | [25] | |||
Interacting Protein Name | Paired amphipathic helix protein Sin3a (SIN3A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [26] | |||
2 | Affinity Capture-Western | [10] | |||
Interacting Protein Name | Transcription initiation factor TFIID subunit 6 (TAF6) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MGC:8964; TAF(II)70; TAF(II)80; TAF2E; TAFII.70; TAFII.80; TAFII70; TAFII80; TAFII85 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Co-fractionation | [27] | |||
Interacting Protein Name | Transcription initiation factor TFIID subunit 9 (TAF9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MGC:5067; STAF31/32; TAF2G; TAFII.31; TAFII.32; TAFII31; TAFII32; TAFIID32 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Reconstituted Complex | [28] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol. 2004 Jul;24(13):5639-49. | ||||
REF 2 | SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell. 2013 Jul 18;154(2):297-310. | ||||
REF 3 | Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases. J Biol Chem. 2012 Aug 10;287(33):27275-89. | ||||
REF 4 | Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells. Oncogene. 2010 Sep 9;29(36):5019-31. | ||||
REF 5 | Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex. Mol Oncol. 2017 Apr;11(4):373-387. | ||||
REF 6 | WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket. J Biol Chem. 2008 Dec 12;283(50):35258-64. | ||||
REF 7 | Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inh... J Biol Chem. 2016 Oct 21;291(43):22357-22372. | ||||
REF 8 | A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes. J Mol Biol. 2014 Jun 12;426(12):2283-99. | ||||
REF 9 | MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8342-7. | ||||
REF 10 | ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell. 2002 Nov;10(5):1119-28. | ||||
REF 11 | Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation. J Biol Chem. 2014 Jan 10;289(2):868-84. | ||||
REF 12 | Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell. 2010 Jun 25;141(7):1183-94. | ||||
REF 13 | Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription. J Mol Biol. 2010 Jul 9;400(2):137-44. | ||||
REF 14 | Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Mol Cell Biol. 2001 May;21(10):3589-97. | ||||
REF 15 | Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization. Cancer Res. 2008 Aug 1;68(15):6199-207. | ||||
REF 16 | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat Commun. 2013;4:1531. | ||||
REF 17 | Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell. 2005 Jun 17;121(6):873-85. | ||||
REF 18 | MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol Cell Biol. 2001 Apr;21(7):2249-58. | ||||
REF 19 | Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation do... J Biol Chem. 2002 Nov 8;277(45):43168-74. | ||||
REF 20 | Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6629-34. | ||||
REF 21 | The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell. 2005 Oct 21;123(2):207-18. | ||||
REF 22 | MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14765-70. | ||||
REF 23 | Interaction of MLL amino terminal sequences with menin is required for transformation. Cancer Res. 2007 Aug 1;67(15):7275-83. | ||||
REF 24 | The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol. 2013 Dec;33(23):4745-54. | ||||
REF 25 | The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 2006 Mar 1;20(5):586-600. | ||||
REF 26 | A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell. 2010 Feb 17;17(2):198-212. | ||||
REF 27 | A census of human soluble protein complexes. Cell. 2012 Aug 31;150(5):1068-81. | ||||
REF 28 | Divergent hTAFII31-binding motifs hidden in activation domains. J Biol Chem. 2000 May 26;275(21):15912-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.